Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Hypofractionated stereotactic radiotherapy combined with chemotherapy or not in the management of recurrent malignant gliomas: A systematic review and meta-analysis.

Hu YJ, Zhang LF, Ding C, Chen D, Chen J.

Clin Neurol Neurosurg. 2019 Aug;183:105401. doi: 10.1016/j.clineuro.2019.105401. Epub 2019 Jun 25. Review.

PMID:
31260910
2.

Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis.

Hu YJ, Chen D, Zhang LF, Chen J.

World Neurosurg. 2019 Jul;127:176-185. doi: 10.1016/j.wneu.2019.03.297. Epub 2019 Apr 6. Review.

PMID:
30959254
3.

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.

Vordermark D, Kölbl O, Ruprecht K, Vince GH, Bratengeier K, Flentje M.

BMC Cancer. 2005 May 30;5:55.

4.

Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.

Fatima N, Meola A, Pollom EL, Soltys SG, Chang SD.

Neurosurg Focus. 2019 Jun 1;46(6):E2. doi: 10.3171/2019.3.FOCUS1970.

PMID:
31153149
5.

Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.

Meniai-Merzouki F, Bernier-Chastagner V, Geffrelot J, Tresch E, Lacornerie T, Coche-Dequeant B, Lartigau E, Pasquier D.

Sci Rep. 2018 Sep 12;8(1):13666. doi: 10.1038/s41598-018-32124-8.

6.

Anti-angiogenic therapy for high-grade glioma.

Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M.

Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218. doi: 10.1002/14651858.CD008218.pub4.

PMID:
30480778
7.

Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.

Dincoglan F, Beyzadeoglu M, Sager O, Demiral S, Gamsiz H, Uysal B, Ebruli C, Akin M, Oysul K, Sirin S, Dirican B.

Tumori. 2015 Mar-Apr;101(2):179-84. doi: 10.5301/tj.5000236. Epub 2015 Mar 19.

PMID:
25791534
8.

Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.

Märtens B, Janssen S, Werner M, Frühauf J, Christiansen H, Bremer M, Steinmann D.

BMC Cancer. 2012 Oct 25;12:497. doi: 10.1186/1471-2407-12-497.

9.

Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.

Dincoglan F, Sager O, Uysal B, Demiral S, Gamsiz H, Gündem E, Elcim Y, Dirican B, Beyzadeoglu M.

Indian J Cancer. 2019 Jul-Sep;56(3):202-206. doi: 10.4103/ijc.IJC_345_18.

10.

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).

Lesueur P, Lequesne J, Barraux V, Kao W, Geffrelot J, Grellard JM, Habrand JL, Emery E, Marie B, Thariat J, Stefan D.

Radiat Oncol. 2018 Jul 28;13(1):138. doi: 10.1186/s13014-018-1083-1.

11.

Radiotherapy for diffuse brainstem glioma in children and young adults.

Hu X, Fang Y, Hui X, Jv Y, You C.

Cochrane Database Syst Rev. 2016 Jun 27;(6):CD010439. doi: 10.1002/14651858.CD010439.pub2. Review.

PMID:
27378212
12.

Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R.

Strahlenther Onkol. 2009 Apr;185(4):235-40. doi: 10.1007/s00066-009-1753-x. Epub 2009 Apr 16.

PMID:
19370426
13.

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.

Bilger A, Bretzinger E, Fennell J, Nieder C, Lorenz H, Oehlke O, Grosu AL, Specht HM, Combs SE.

Cancer Med. 2018 Jun;7(6):2350-2359. doi: 10.1002/cam4.1486. Epub 2018 May 9.

14.

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):156-63. doi: 10.1016/j.ijrobp.2008.10.043. Epub 2009 Jan 23.

15.

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.

Reynaud T, Bertaut A, Farah W, Thibouw D, Crehange G, Truc G, Vulquin N.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806498. doi: 10.1177/1533033818806498.

16.

Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach.

Steinmann D, Maertens B, Janssen S, Werner M, Frühauf J, Nakamura M, Christiansen H, Bremer M.

J Cancer Res Clin Oncol. 2012 Sep;138(9):1523-9. doi: 10.1007/s00432-012-1227-x. Epub 2012 Apr 24.

PMID:
22526164
17.

HFSRT of the resection cavity in patients with brain metastases.

Specht HM, Kessel KA, Oechsner M, Meyer B, Zimmer C, Combs SE.

Strahlenther Onkol. 2016 Jun;192(6):368-76. doi: 10.1007/s00066-016-0955-2. Epub 2016 Mar 10.

PMID:
26964777
18.

A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases.

Bi N, Ma Y, Xiao J, Zhang H, Xu Y, Tian Y, Li J, Zhang Y, Liu Q, Wang K, Deng L, Wang W, Chen X, Liu F, Zhao R, Yang S, Huang X, Yi J, Hu C, Li Y.

Oncologist. 2019 Sep;24(9):e914-e920. doi: 10.1634/theoncologist.2018-0702. Epub 2019 Apr 17.

PMID:
30996008
19.

Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.

Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G.

J Neurooncol. 2007 Feb;81(3):287-94. Epub 2006 Sep 20.

PMID:
17031558
20.

Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM.

Jia A, Pannullo SC, Minkowitz S, Taube S, Chang J, Parashar B, Christos P, Wernicke AG.

Cureus. 2016 Mar 17;8(3):e536. doi: 10.7759/cureus.536.

Supplemental Content

Support Center